These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 22990640)

  • 41. Estimation of antithyroid drug dose in Graves' disease: value of quantification of thyroid blood flow with color duplex sonography.
    Saleh A; Fürst G; Feldkamp J; Godehardt E; Grust A; Mödder U
    Ultrasound Med Biol; 2001 Aug; 27(8):1137-41. PubMed ID: 11527601
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Outcome of pediatric Graves' disease after treatment with antithyroid medication and radioiodine.
    Ward L; Huot C; Lambert R; Deal C; Collu R; Van Vliet G
    Clin Invest Med; 1999 Aug; 22(4):132-9. PubMed ID: 10497711
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Treatment of hyperthyroidism due to Graves' disease: what is the recommended antithyroid drug during pregnancy?].
    Caron P
    J Gynecol Obstet Biol Reprod (Paris); 2013 May; 42(3):232-7. PubMed ID: 23312275
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Metamorphic thyroid autoimmunity in Down Syndrome: from Hashimoto's thyroiditis to Graves' disease and beyond.
    Aversa T; Valenzise M; Salerno M; Corrias A; Iughetti L; Radetti G; De Luca F; Wasniewska M
    Ital J Pediatr; 2015 Nov; 41():87. PubMed ID: 26558364
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of methimazole and propylthiouracil in patients with hyperthyroidism caused by Graves' disease.
    Nakamura H; Noh JY; Itoh K; Fukata S; Miyauchi A; Hamada N
    J Clin Endocrinol Metab; 2007 Jun; 92(6):2157-62. PubMed ID: 17389704
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Persistent Graves' hyperthyroidism despite rapid negative conversion of thyroid-stimulating hormone-binding inhibitory immunoglobulin assay results: a case report.
    Ohara N; Kaneko M; Kitazawa M; Uemura Y; Minagawa S; Miyakoshi M; Kaneko K; Kamoi K
    J Med Case Rep; 2017 Feb; 11(1):32. PubMed ID: 28162094
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Is there a methimazole dose effect on remission rate in Graves' disease? Results from a long-term prospective study. The European Multicentre Trial Group of the Treatment of Hyperthyroidism with Antithyroid Drugs.
    Benker G; Reinwein D; Kahaly G; Tegler L; Alexander WD; Fassbinder J; Hirche H
    Clin Endocrinol (Oxf); 1998 Oct; 49(4):451-7. PubMed ID: 9876342
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Increase of interferon-γ inducible CXCL9 and CXCL11 serum levels in patients with active Graves' disease and modulation by methimazole therapy.
    Antonelli A; Ferrari SM; Corrado A; Ferrannini E; Fallahi P
    Thyroid; 2013 Nov; 23(11):1461-9. PubMed ID: 23721189
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Administration of thyroxine in treated Graves' disease. Effects on the level of antibodies to thyroid-stimulating hormone receptors and on the risk of recurrence of hyperthyroidism.
    Hashizume K; Ichikawa K; Sakurai A; Suzuki S; Takeda T; Kobayashi M; Miyamoto T; Arai M; Nagasawa T
    N Engl J Med; 1991 Apr; 324(14):947-53. PubMed ID: 1900575
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of antithyroid drugs efficacy on P wave changes in patients with Graves' disease.
    Berker D; Işik S; Canbay A; Aydin Y; Tütüncü Y; Delibaşi T; Güler S
    Anadolu Kardiyol Derg; 2009 Aug; 9(4):298-303. PubMed ID: 19666432
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Graves' hyperthyroidism-related pancytopenia: a case report with literature review.
    Scappaticcio L; Bellastella G; Maiorino MI; Longo M; Catalano C; Esposito K; Paolisso G; Rizzo MR
    Hormones (Athens); 2021 Mar; 20(1):93-100. PubMed ID: 32638234
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Methimazole therapy in Graves' disease influences the abnormal expression of CD69 (early activation antigen) on T cells.
    Corrales JJ; López A; Ciudad J; Mories MT; Miralles JM; Orfao A
    J Endocrinol; 1997 Dec; 155(3):491-500. PubMed ID: 9487994
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serum concentrations of adiponectin in patients with hyperthyroidism before and after control of thyroid function.
    Hsieh CJ; Wang PW
    Endocr J; 2008 Jul; 55(3):489-94. PubMed ID: 18469483
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Plasma atrial natriuretic peptide, plasma renin activity and aldosterone during treatment of hyperthyroidism due to Graves' disease.
    Shigematsu S; Iwasaki T; Aizawa T; Ishihara M; Shinoda T; Yamada T; Sato A; Takemura Y
    Horm Metab Res; 1989 Sep; 21(9):514-8. PubMed ID: 2531114
    [TBL] [Abstract][Full Text] [Related]  

  • 55. High dose of (131)I therapy for the treatment of hyperthyroidism caused by Graves' disease.
    Alexander EK; Larsen PR
    J Clin Endocrinol Metab; 2002 Mar; 87(3):1073-7. PubMed ID: 11889166
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Influence of thyroid volume on the effect of methimazole in Japanese subjects with mild Graves' disease.
    Kimura T; Matsuki M; Kaneto H; Mune T; Kaku K
    Eur J Intern Med; 2016 Dec; 36():e31-e32. PubMed ID: 27601286
    [No Abstract]   [Full Text] [Related]  

  • 57. Treatment of hyperthyroidism with antithyroid drugs corrects mild neutropenia in Graves' disease.
    Aggarwal N; Tee SA; Saqib W; Fretwell T; Summerfield GP; Razvi S
    Clin Endocrinol (Oxf); 2016 Dec; 85(6):949-953. PubMed ID: 27291145
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The use of konjac glucomannan to lower serum thyroid hormones in hyperthyroidism.
    Azezli AD; Bayraktaroglu T; Orhan Y
    J Am Coll Nutr; 2007 Dec; 26(6):663-8. PubMed ID: 18187431
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Serum leptin and ghrelin levels in premenopausal women with stable body mass index during treatment of thyroid dysfunction.
    Braclik M; Marcisz C; Giebel S; Orzeł A
    Thyroid; 2008 May; 18(5):545-50. PubMed ID: 18466078
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment of Swedish Patients with Graves' Hyperthyroidism Is Associated with Changes in Acylcarnitine Levels.
    Al-Majdoub M; Lantz M; Spégel P
    Thyroid; 2017 Sep; 27(9):1109-1117. PubMed ID: 28699427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.